The efficacy of pramipixole as an adjuvant treatment with citalopram for treating major depressive disorder
Phase 2
- Conditions
- Major depressive disorder.Depressive episode
- Registration Number
- IRCT201312263930N30
- Lead Sponsor
- Shiraz University of Medical sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
patients aged 18 to 65 years old, major depressive disorder using DSM-IV diagnostic criteria.
Exclusion criteria: serious uncontrolled medical conditions, bipolar mood disorder.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Depression. Timepoint: baseline, week 2, week 4, and week 6. Method of measurement: Hamilton Derepssion Rating Scale.
- Secondary Outcome Measures
Name Time Method